NCT06393556

Brief Summary

The study, set to take place at Gold Coast University Hospital in Australia, will be conducted as a randomized controlled trial. Patients preparing for gynecological cancer surgery will be recruited and randomly assigned to one of two groups: those who will receive standard care plus a virtual reality (VR) intervention, and those who will receive only standard care. Standard care encompasses the usual pre-operative procedures and support provided by the hospital staff. We hypothesize that immersing patients in a preparatory virtual environment that shows them what they are to expect during their upcoming hospital stay for surgery, could help reduce their anxiety levels.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 10, 2019

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 4, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

February 4, 2022

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

April 26, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 1, 2024

Completed
Last Updated

May 31, 2024

Status Verified

May 1, 2024

Enrollment Period

2.7 years

First QC Date

April 26, 2024

Last Update Submit

May 29, 2024

Conditions

Keywords

anxietyvirtual realitygynecologic-oncological surgery

Outcome Measures

Primary Outcomes (1)

  • Anxiety

    Anxiety level measured by a 6-item visual scale (1 .. least anxiety, 6 ... highest anxiety)

    T0 (before randomization), T1 (same day as T0, but after care as usual +/- VR; usually inside 1 hour), T2 (days/weeks later, before surgical procedure - exact gap is unknown; expected: >3 days, median around 4-7 weeks)

Study Arms (2)

Virtual reality

EXPERIMENTAL

Care-as-usual + virtual reality intervention during a pre-operative visit

Other: Virtual reality experience

Control

NO INTERVENTION

Care-as-usual during a pre-operative visit

Interventions

An immersive VR experience, delivered using a VR head-mounted display, of the real-world environment at the hospital, featuring the pre-operative admission suite, pre-anesthetic bay, operating theatre, postoperative recovery room, and medical staff.

Virtual reality

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Gynecological oncology patients with scheduled surgery

You may not qualify if:

  • Language barrier
  • Inability to provide consent
  • Having undergone any procedure at the operating theatre in the previous 5 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Gold Coast University Hospital

Southport, Queensland, 4215, Australia

Location

Related Publications (2)

  • Cao X, Yumul R, Elvir Lazo OL, Friedman J, Durra O, Zhang X, White PF. A novel visual facial anxiety scale for assessing preoperative anxiety. PLoS One. 2017 Feb 14;12(2):e0171233. doi: 10.1371/journal.pone.0171233. eCollection 2017.

    PMID: 28196099BACKGROUND
  • Schmid BC, Marsland D, Jacobs E, Rezniczek GA. A Preparatory Virtual Reality Experience Reduces Anxiety before Surgery in Gynecologic Oncology Patients: A Randomized Controlled Trial. Cancers (Basel). 2024 May 17;16(10):1913. doi: 10.3390/cancers16101913.

MeSH Terms

Conditions

Anxiety Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Bernd C Schmid, MD

    Gold Coast University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Care provider measuring the primary outcome scale at T2 was not aware of the intervention given at T0/1. Statistical data analysis initially was prepared not knowing which group was the intervention group.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: 1:1 randomization
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Head of Ob/Gyn Research Lab (MHH)

Study Record Dates

First Submitted

April 26, 2024

First Posted

May 1, 2024

Study Start

May 10, 2019

Primary Completion

February 4, 2022

Study Completion

February 4, 2022

Last Updated

May 31, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will share

De-identified data will be shared upon reasonable request for purposes that have been approved by the respective Institutional Review Board

Shared Documents
STUDY PROTOCOL, ICF
Time Frame
After publication
Access Criteria
Reasonable request; approval of intended use by an Institutional Review Board

Locations